A-232
Overview
A-232 is a chemical compound that belongs to the class of nerve agents known as Novichok agents. These agents were developed in the Soviet Union during the late stages of the Cold War and are known for their high toxicity and potential use in chemical warfare. A-232 is part of a series of compounds designed to be more potent than traditional nerve agents like sarin and VX.
Chemical Properties
A-232 is an organophosphate compound, which means it contains phosphorus bonded to carbon and oxygen atoms. The chemical structure of A-232 is designed to inhibit the enzyme acetylcholinesterase, leading to an accumulation of the neurotransmitter acetylcholine in the synaptic cleft. This results in continuous stimulation of muscles, glands, and central nervous system structures, causing the symptoms associated with nerve agent poisoning.
Mechanism of Action
The primary mechanism of action of A-232, like other nerve agents, is the inhibition of acetylcholinesterase. This enzyme is responsible for breaking down acetylcholine in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, leading to overstimulation of muscarinic and nicotinic receptors. This overstimulation causes a range of symptoms, including muscle twitching, respiratory distress, and potentially death due to respiratory failure.
Symptoms of Exposure
Exposure to A-232 can result in a variety of symptoms, depending on the dose and route of exposure. Common symptoms include:
- Miosis (constriction of the pupils)
- Excessive salivation
- Sweating
- Muscle twitching
- Convulsions
- Respiratory distress
- Loss of consciousness
Treatment
The treatment for exposure to A-232 involves the use of antidotes such as atropine and pralidoxime. Atropine works by blocking the muscarinic effects of acetylcholine, while pralidoxime reactivates acetylcholinesterase by removing the phosphate group attached by the nerve agent. Supportive care, including mechanical ventilation, may also be necessary in severe cases.
Development and History
The development of Novichok agents, including A-232, was part of a secret Soviet program aimed at creating more effective chemical weapons. These agents were designed to be undetectable by standard NATO chemical detection equipment and to circumvent the Chemical Weapons Convention. The existence of Novichok agents was revealed by defectors in the 1990s, leading to increased international awareness and concern.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD